Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
UpViser Oy
OY
Dissolved
Y-tunnus 2123858-7
C/O Mediq Suomi Oy Vuoritontunkuja 6, 02200
Espoo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2007 · 19 years old
0 employees
www.upviser.fi
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
UpViser Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
2M
5M
7M
9M
6M
2019
6M
2020
8M
2021
EBITDA
EUR millions
1M
1M
1M
0M
0M
1M
2019
0M
-100%
2020
0M
0%
2021
Income statement
EUR thousands
Item
2019
2020
2021
Revenue
6 288
6 106
8 187
Staff expenses
−1 333
−1 348
−1 551
EBITDA
599
468
167
Depreciation & amort.
−11
−10
−8
EBIT
588
459
159
Net financials
180
499
42
Profit before tax
768
958
5 580
Tax
122
93
−1 297
Net profit
646
865
6 876
Balance sheet
EUR thousands
Item
2019
2020
2021
Total assets
3 170
3 669
8 720
Equity
1 648
2 074
7 932
Long-term debt
269
331
10
Short-term debt
1 253
1 264
778
Total debt
1 522
1 595
788
Financial ratios
5-year trend
EBITDA-margin
2.0%
This company
15.8%
Market median
-87% vs market
2019
2021
Soliditetsgrad
91.0%
This company
38.2%
Market median
+138% vs market
2019
2021
Egenkapitalforrentning
86.7%
This company
18.4%
Market median
+371% vs market
2019
2021
Nettoresultatgrad
84.0%
This company
8.1%
Market median
+937% vs market
2019
2021
Aktivomsætning
0.94×
This company
1.12×
Market median
+16% vs market
2019
2021
Gæld/egenkapital
0.10×
This company
0.62×
Market median
+84% vs market
2019
2021
Annual reports & filings
Annual report 2021
Filed via PRH / YTJ · Period 2020-11-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2019-11-01 – 2020-10-31
View
PDF
Annual report 2019
Filed via PRH / YTJ · Period 2018-11-01 – 2019-10-31
View
PDF
More on UpViser Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
